See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI100.86▲ 1.40%
← C page
XStocksXray
Research report · 22 October 2026

Citigroup Inc (C)

Financials · Diversified Banks · US stock · price as of 22 Oct 2026

Key indicators

Price$122.51
52-week range$95.00 – $147.96
Market cap$229.5B
P/E (trailing)16.2×
Dividend yield2.0%
Revenue (last 12 months)$85.2B
Revenue growth (3y a year)4.2%
Price / book1.1×
Return on equity6.7%

Fair value

Fair value (average of valid models)$107.90 middle half of models $94 – $113
Versus priceFair−12% to fair value
P/E multiple$113.34
P/B multiple$93.86
P/S multiple$108.60
Dividend discount, stable$82.14
Dividend discount, multi-stage$141.58
Model uncertaintyMedium

X-Ray Score

24/ 100 · Medium confidence · ahead of 0% of sector peers
Valuation15
Growth28
Profitability16
Financial health36
Dividends37

Five-year price chart navy: price · brown: 200-day average · blue band: fair value range

28.2959.1089.91121152Fair value $1082021-102023-012024-042025-072026-10

Executive summary

Consumers, companies, institutions and governments are served by Citigroup, a global bank. Its businesses include treasury and trade services for multinational clients, securities services, markets trading, investment banking, wealth management and credit cards and retail banking in the United States. It operates in many countries, and the firm is organised into several business lines that serve different client groups.

Revenue was $85.2 billion over the last twelve months, drawn from interest on loans and investments, fees for services such as payments, trading, advice and wealth management, and card income. Revenue was $85.2 billion over the last twelve months and has grown at 4.2% a year across the last three years. The dividend yield is 2.0%.

StocksXray gives Citigroup Inc an X-Ray Score of 24 out of 100 (medium confidence), ahead of 0% of the S&P 500 stocks in its sector. Its strongest lens is dividends (37) and its weakest is valuation (15).

Our fair value (the average of the valid models) is $107.90 (range $93.86 to $113.34). At $122.51 the stock trades 14% above that value, so the label is "Fair" with medium model uncertainty. Fair value is a range, not a price target.

stocksxray.com · page 1
XStocksXray
Citigroup Inc (C)

Valuation history multiples at each fiscal year-end price; the last column uses today's price and the last twelve months

FY2021FY2022FY2023FY2024FY2025Now
Price$51.28$39.95$47.54$67.47$114.95$122.51
Market cap$105.1B$78.5B$93.0B$130.9B$215.3B$229.5B
P/E5.1×5.7×11.8×11.4×16.4×16.2×
Price / book0.5×0.4×0.5×0.6×1.0×1.1×
Dividend yield–––––2.02%

Fundamentals checklist ● 0 Good · ● 1 Average · ● 6 Bad · each check graded against the sector

Risk models

Piotroski F-Score4 of 9Bad

Growth

EPS growth (3y)−0.0%Bad
Revenue growth (3y)4.2%Bad
Growth consistency80%Bad

Valuation

Fair value vs price0.9×Bad

Profitability

Return on invested capital5.7%Bad
Operating margin23.3%Average
stocksxray.com · page 2
XStocksXray
Citigroup Inc (C)

Financials US$ millions, from SEC filings; last column is the last twelve months

Income statementFY21FY22FY23FY24FY25LTM
Revenue71,88475,33878,06680,72285,22585,225
Net income21,95214,8459,22812,68214,30614,306
Diluted EPS ($)10.147.004.045.946.997.58
Net margin30.5%19.7%11.8%15.7%16.8%16.8%
Balance sheetFY21FY22FY23FY24FY25LTM
Total assets2,291,0002,417,0002,412,0002,352,9452,657,2022,657,202
Cash262,033342,025260,932276,532349,579349,579
Total debt298,365344,232344,298364,721387,646387,646
Equity201,972201,189205,453208,598212,291212,291
Dividend per share ($)–––––2.32

Revenue and net income US$ billions: navy revenue, teal net income

FY21FY22FY23FY24FY25

Margins blue gross, teal operating, brown net

0%39%78%117%FY21FY22FY23FY24FY25

Latest quarters

Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue ($M)20,20919,46521,59621,66822,09019,871
Growth vs a year earlier+0.3%+14.2%+2.8%+8.2%+9.3%+2.1%
Net income ($M)3,2382,8564,0644,0193,7522,471
Diluted EPS ($)1.51–1.961.961.86–
stocksxray.com · page 3
XStocksXray
Citigroup Inc (C)

Peers in Diversified Banks

CompanyX-Ray
C · Citigroup Inc24
USB · Us Bancorp De63
PNC · Pnc Financial Services Gro...49
JPM · Jpmorgan Chase & Co49
BAC · Bank Of America Corp48

Market Compass outlook for Financials: Favourable (71/100). It blends regime history, macro sensitivity, momentum and valuation.

Returns

1 week−0.6%
1 month−7.5%
3 months−6.9%
6 months−4.6%
1 year+29.9%
3 years+238.4%
5 years+103.6%

Technical summary

DailyStrongly bearish3 bullish · 1 neutral · 12 bearish
WeeklyNeutral5 bullish · 1 neutral · 6 bearish
MonthlyStrongly bullish6 bullish · 1 neutral · 1 bearish
50-day / 200-day average$131.61 / $125.72
52-week low / high$95.00 / $147.96
Classic pivot, support and resistanceS2 119.56 · S1 121.04 · P – · R1 123.96 · R2 125.40

Recent dividends

Ex-dividend dateAmount per share
3 Aug 2026$0.6700
4 May 2026$0.6000
2 Feb 2026$0.6000
3 Nov 2025$0.6000
4 Aug 2025$0.6000
5 May 2025$0.5600
stocksxray.com · page 4
XStocksXray
Citigroup Inc (C)

Strengths

No check stands out as a clear strength against its sector.

Risks and weak spots

  • Piotroski F-Score is weak against Financials peers (4 of 9).
  • EPS growth (3y) is weak against Financials peers (−0.0%).
  • Revenue growth (3y) is weak against Financials peers (4.2%).
  • Growth consistency is weak against Financials peers (80%).
  • Fair value vs price is weak against Financials peers (0.9×).
  • Return on invested capital is weak against Financials peers (5.7%).

Latest SEC filings

DateFormItems
22 Oct 20268-K5.02,9.01
13 Oct 20268-K2.02,9.01
24 Sep 20268-K9.01
6 Aug 202610-Q
14 Jul 20268-K2.02,9.01
21 May 20268-K5.02,5.07,9.01
7 May 202610-Q
14 Apr 20268-K2.02,9.01

How to read this report

Every number comes from SEC filings, end-of-day prices and the StocksXray models described on the methodology page. The X-Ray Score ranks each metric against the company's own sector. Fair value is the average of up to 15 valuation models, most of them anchored to the company's own multiples, so it stays near the price and should be read as a range, not a point. Analyst ratings, price targets and earnings-call summaries are not part of this report. Educational research, not financial advice; read the disclaimer.

stocksxray.com · page 5 · generated 23 Oct 2026